Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

14,474 total articles

Nano Labs (NA): A Microcap Chip Play Betting on AI Data Center Momentum

Nano Labs (NA): A Microcap Chip Play Betting on AI Data Center Momentum

Nano Labs is a Hangzhou-based fabless designer of high-throughput and vision computing chips that has signaled ambitions in AI data center infrastructure. The stock is a microcap ($44.6M market cap) trading near $1.92 with thin volume and elevated short interest at points this year. I view NA as a speculative swing trade: the upside is tied to exec…

Cummins: Collecting the Toll on the Power Bottleneck

Cummins: Collecting the Toll on the Power Bottleneck

Cummins is morphing from an engine supplier into the infrastructure-grade vendor for stranded power needs. With Power Systems showing high margins and a multi-year backlog, the stock looks actionable on a medium-term bounce. Trade idea: buy at $621.45, stop $560.00, target $740.00 (primary) — horizon ~45 trading days.

Buying the AI Neocloud: A High-Risk Path Toward $1,000 for NBIS

Buying the AI Neocloud: A High-Risk Path Toward $1,000 for NBIS

Nebius Group (NBIS) has sprinted into the AI infrastructure spotlight with outsized revenue growth, a $27B deal, and strategic capital from Nvidia. That combination gives the stock a legitimate runway toward $1,000 if growth and margins continue to accelerate. This is an actionable long trade for disciplined investors who can tolerate high volatili…

Doubling Down on Palantir: Tactical Buy as AI Revenue Tears Higher

Doubling Down on Palantir: Tactical Buy as AI Revenue Tears Higher

Palantir's Q2 cadence and guidance have pushed enterprise AI adoption into hyperdrive: revenue growth near 93% with U.S. commercial revenue up 149%. Valuation is rich, but cash generation, margin profile, and technical momentum make a disciplined long with a $170 entry and $220 target a high-conviction trade for the next 180 trading days.

Kinross: Lobo-Marte Reinforces a Growth Re-rate — Tactical Long Idea

Kinross: Lobo-Marte Reinforces a Growth Re-rate — Tactical Long Idea

Kinross Gold (KGC) is trading near $27.25 after an S&P upgrade to BBB and with a reported net cash position of $1.9B and total liquidity of $4.4B. Lobo-Marte and a pipeline of projects improve growth visibility; combine that with record free cash flow and steady shareholder returns and you have a constructive setup for a swing trade. Entry $27.25, …

TFSL: Ride the Regional Bank Recovery — A Mid-term Long Trade After an Earnings Pop and Loan Momentum

TFSL: Ride the Regional Bank Recovery — A Mid-term Long Trade After an Earnings Pop and Loan Momentum

TFS Financial (TFSL) looks set to benefit from steady loan growth, a hefty cash dividend and improving investor sentiment in regional banks. Valuation is reasonable on a price-to-book around 2.6 and the stock sits below its 52-week high, giving room for a mid-term rebound. I outline a precise entry, stop and target for a 45-trading-day swing trade …

GeneDx Recovery: Why OPKO's Diagnostics Unit May Have Turned the Corner

GeneDx Recovery: Why OPKO's Diagnostics Unit May Have Turned the Corner

OPKO (OPK) trades like a beaten-down biotech but carries a diagnostics franchise and a balance sheet that make a measured long position attractive. With a market cap near $1.02B, EV/sales ~1.8x, improving technicals and upcoming program milestones with Entera Bio, I prefer a long trade sized modestly for recovery upside while protecting against con…

Buy the Dip in STMicro: Tactical Long into a Sector Pullback

Buy the Dip in STMicro: Tactical Long into a Sector Pullback

STMicroelectronics (STM) has given back a large chunk of recent gains and is trading near $52.22 after a corrective stretch. The company still benefits from structural growth in automotive microcontrollers, power electronics for EVs, and sensors. With a market cap near $47.4B, positive free cash flow, and improving technical momentum, a disciplined…

Edgewise After Servier: A Funded Path to the Cardio Catalysts

Edgewise After Servier: A Funded Path to the Cardio Catalysts

Edgewise Therapeutics has moved from a pure binary biotech to a company with optionality: an announced licensing arrangement with Servier should provide non-dilutive capital that extends runway for EDG-7500 and sevasemten. The trade: go long around current levels to capture upside into upcoming pivotal catalysts while protecting against trial and r…

Commercial Metals: Rebuilding the Base — A Tactical Long on CMC

Commercial Metals: Rebuilding the Base — A Tactical Long on CMC

Commercial Metals Company (CMC) looks like a constructive swing trade today. The business is cash-generative, pays a reliable dividend, and is diversifying into precast concrete after a $675M acquisition. Valuation is reasonable with a P/E near 13.7 and EV/EBITDA around 13.5. Technicals are neutral; catalyst flow and improving free cash flow suppor…

Materion's Growing Order Book and Technical Setup Make a Mid-Term Buy

Materion's Growing Order Book and Technical Setup Make a Mid-Term Buy

Materion (MTRN) looks buyable at current levels after a pullback. The company sells specialized materials for electronics, aerospace and optics; recent wins in gold targets and precision coatings plus a healthy backlog support revenue growth. Valuation is rich versus historical norms but the trade offers a defined entry at $266.61 with a $300 targe…

Cerus (CERS): A Blood-Safety Underdog Worth a Mid-Term Spec

Cerus (CERS): A Blood-Safety Underdog Worth a Mid-Term Spec

Cerus operates the INTERCEPT blood-safety platform for platelets and plasma. At a market cap near $600M and trading comfortably off its 52-week low, CERS combines recurring revenue characteristics with a short-interest backdrop and improving technicals that make a focused long swing trade attractive. This is a tactical, mid-term (45 trading days) t…

SMCI: Deep-Value AI Play — Growth Is Real, Rumors Are the Roadblock

SMCI: Deep-Value AI Play — Growth Is Real, Rumors Are the Roadblock

Super Micro (SMCI) just reported staggering top-line momentum and margin improvement tied to AI server demand, yet the stock trades at a valuation that discounts much of that growth. The trade: a long position sized for high volatility with a clear stop and a $60 target over a 180-trading-day horizon, accepting legal and financing risk as the prima…

SK hynix: Buy the Dip While the Market Prices in Doom, Not Data

SK hynix: Buy the Dip While the Market Prices in Doom, Not Data

SK hynix is trading well below its 52-week high after a volatile few weeks of headlines. The company sits on strong margins, sizable cash flow, and leadership in high-bandwidth memory. With a market cap near $1.17 trillion, a forward P/E ~11 and technical indicators showing improving momentum, this trade targets a rebound toward $190 while limiting…